3D In Vitro Technology for Drug Discovery

被引:16
|
作者
Hosseinkhani, Hossein [1 ]
机构
[1] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan
关键词
3D scaffold; toxicity testing in vitro; replacement alternative; hydrogel; biochip;
D O I
10.2174/157488612800492753
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three-dimensional (3D) in vitro systems that can mimic organ and tissue structure and function in vivo, will be of great benefit for a variety of biological applications from basic biology to toxicity testing and drug discovery. There have been several attempts to generate 3D tissue models but most of these models require costly equipment, and the most serious disadvantage in them is that they are too far from the mature human organs in vivo. Because of these problems, research and development in drug discovery, toxicity testing and biotech industries are highly expensive, and involve sacrifice of countless animals and it takes several years to bring a single drug/product to the market or to find the toxicity or otherwise of chemical entities. Our group has been actively working on several alternative models by merging biomaterials science, nanotechnology and biological principles to generate 3D in vitro living organs, to be called "Human Organs-on-Chip", to mimic natural organ/tissues, in order to reduce animal testing and clinical trials. We have fabricated a novel type of mechanically and biologically bio-mimicking collagen-based hydrogel that would provide for interconnected mini-wells in which 3D cell/organ culture of human samples in a manner similar to human organs with extracellular matrix (ECM) molecules would be possible. These products mimic the physical, chemical, and biological properties of natural organs and tissues at different scales. This paper will review the outcome of our several experiments so far in this direction and the future perspectives.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [41] Spatially patterned, 3D in vitro models of cancer metastasis to bone for elucidating key drivers of metastasis and drug discovery
    Diaz, Eva C. Gonzalez
    Tai, Michelle
    Monette, Callan E.
    Wu, Joy
    Yang, Fan
    CANCER RESEARCH, 2022, 82 (12)
  • [42] Why choose 3D bioprinting? Part III: printing in vitro 3D models for drug screening
    Yong He
    Jing Nie
    Mingjun Xie
    Qing Gao
    Bio-Design and Manufacturing, 2020, 3 : 160 - 163
  • [43] Why choose 3D bioprinting? Part III: printing in vitro 3D models for drug screening
    He, Yong
    Nie, Jing
    Xie, Mingjun
    Gao, Qing
    BIO-DESIGN AND MANUFACTURING, 2020, 3 (03) : 160 - 163
  • [44] Biological Scaffolds in 3D Cell Models: Driving Innovation in Drug Discovery
    Dave, Raj
    Pandey, Kshipra
    Patel, Ritu
    Gour, Nidhi
    Bhatia, Dhiraj
    STEM CELL REVIEWS AND REPORTS, 2025, 21 (01) : 147 - 166
  • [45] PROTEIN-STRUCTURE-BASED DRUG DISCOVERY USING 3D DATABASES
    VANDRIE, JH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 58 - MEDI
  • [46] 3D Co-culture Systems in Drug Discovery and Regenerative Medicine
    Applegate, D. R.
    Naughton, B. A.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2011, 47 : S10 - S10
  • [47] DrugPose: benchmarking 3D generative methods for early stage drug discovery
    Jocys, Zygimantas
    Grundy, Joanna
    Farrahi, Katayoun
    DIGITAL DISCOVERY, 2024, 3 (07): : 1308 - 1318
  • [48] PROTEIN-STRUCTURE-BASED DRUG DISCOVERY USING 3D DATABASES
    VANDRIE, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 15 - CINF
  • [49] Optimization of synthetic hydrogels for the manufacture of 3D organoid model for drug discovery
    Pretto, Stefano
    Miller, Aline
    TISSUE ENGINEERING PART A, 2023, 29 (13-14)
  • [50] Modeling the tumor immune microenvironment for drug discovery using 3D culture
    Lee, Joanna Y.
    Chaudhuri, Ovijit
    APL BIOENGINEERING, 2021, 5 (01)